FastWave Medical Granted Fifth Utility Patent by USPTO for Innovative IVL Technology

FastWave Medical secures fifth utility patent from USPTO for its innovative intravascular lithotripsy technology, aimed at revolutionizing treatment for calcific disease. CEO Scott Nelson emphasizes company’s commitment to advancing patient care through cutting-edge solutions. Visit FastWave Medical’s website for more information.